Louis C. Lucido Bio Cor Rx Inc. (BICX) insider trading activity

Louis C. Lucido is President of BioCorRx Inc.. Currently has a direct ownership of 2.51 Million shares of BICX, which is worth approximately $778,701. The most recent transaction as insider was on Jan 03, 2023, when has been sold 2,000 shares (Common Stock, par value $0.001) at a price of $1.1 per share, resulting in proceeds of $2,200. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 2.51M

4.69% 3M change

409.31% 12M change

Total Value Held $778,701

Louis C. Lucido Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 03 2023	BUY Open market or private purchase	$2,200 $1.1 p/Share	2,000 Added 2.02%	97,059 Common Stock, par valu...
Dec 30 2022	BUY Grant, award, or other acquisition	-	5,319 Added 5.3%	95,059 Common Stock, par valu...
Dec 30 2022	BUY Open market or private purchase	$318 $1.01 p/Share	315 Added 0.35%	89,740 Common Stock, par valu...
Dec 12 2022	BUY Open market or private purchase	$4,200 $0.84 p/Share	5,000 Added 5.3%	89,425 Common Stock, par valu...
Oct 06 2022	BUY Open market or private purchase	$1,067 $1.84 p/Share	580 Added 0.68%	84,425 Common Stock, par valu...
Oct 05 2022	BUY Open market or private purchase	$2,020 $2.02 p/Share	1,000 Added 1.18%	83,845 Common Stock, par valu...
Sep 30 2022	BUY Grant, award, or other acquisition	-	2,450 Added 2.87%	82,835 Common Stock, par valu...
Sep 06 2022	BUY Open market or private purchase	$21 $2.1 p/Share	10 Added 0.01%	82,845 Common Stock, par valu...
Aug 31 2022	BUY Open market or private purchase	$1,293 $2.12 p/Share	610 Added 0.75%	80,385 Common Stock, par valu...
Aug 29 2022	BUY Open market or private purchase	$6,895 $2.11 p/Share	3,268 Added 3.94%	79,775 Common Stock, par valu...
Aug 26 2022	BUY Open market or private purchase	$1,187 $2.12 p/Share	560 Added 0.73%	76,507 Common Stock, par valu...
Aug 25 2022	BUY Open market or private purchase	$1,090 $2.18 p/Share	500 Added 0.65%	75,947 Common Stock, par valu...
Jun 30 2022	BUY Grant, award, or other acquisition	-	2,092 Added 2.7%	75,447 Common Stock, par valu...
Mar 31 2022	BUY Grant, award, or other acquisition	-	1,408 Added 1.88%	73,355 Common Stock, par valu...
Dec 31 2021	BUY Grant, award, or other acquisition	-	1,141 Added 1.56%	71,947 Common Stock, par valu...
Oct 19 2021	BUY Open market or private purchase	$4,960 $3.2 p/Share	1,550 Added 2.14%	70,806 Common Stock, par valu...
Sep 30 2021	BUY Grant, award, or other acquisition	-	1,381 Added 1.98%	68,536 Common Stock, par valu...
Jun 30 2021	BUY Grant, award, or other acquisition	-	1,210 Added 1.77%	67,155 Common Stock, par valu...
Mar 31 2021	BUY Grant, award, or other acquisition	-	2,315 Added 3.39%	65,945 Common Stock, par valu...
Jan 22 2021	BUY Open market or private purchase	$2,880 $1.44 p/Share	2,000 Added 3.05%	63,630 Common Stock, par valu...
Dec 31 2020	BUY Grant, award, or other acquisition	-	4,901 Added 1.84%	261,926 Common Stock, par valu...
Sep 30 2020	BUY Grant, award, or other acquisition	-	2,631 Added 1.01%	257,025 Common Stock, par valu...

LCL

Louis C. Lucido

President

Anaheim, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BICX shares.

Notify only if

Value

Insider Trading

Get notified when an Bio Cor Rx Inc. insider buys or sells BICX shares.

Notify only if

Operation

Value

Type

News

Receive news related to BioCorRx Inc.

Track Activities on BICX

Account